These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33157516)

  • 1. A higher platelet-to-lymphocyte ratio is prevalent in the presence of circulating tumor microemboli and is a potential prognostic factor for non-metastatic colon cancer.
    Abdallah EA; Souza E Silva V; Braun AC; Gasparini VA; Kupper BEC; Tariki MS; Tarazona JGR; Takahashi RM; Aguiar Júnior S; Chinen LTD
    Transl Oncol; 2021 Jan; 14(1):100932. PubMed ID: 33157516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy.
    Zhang D; Zhao L; Zhou P; Ma H; Huang F; Jin M; Dai X; Zheng X; Huang S; Zhang T
    Cancer Cell Int; 2017; 17():6. PubMed ID: 28070168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells and neutrophil-lymphocyte ratio are predictive markers for metastatic colorectal cancer patients.
    Li H; Liu Q; Liang S; Yao P; Lv J; Wang G; Tang R; Zhao T; Li J; Xu L; Ma L; Wang R
    Transl Cancer Res; 2021 Jan; 10(1):288-297. PubMed ID: 35116260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
    Zheng X; Fan L; Zhou P; Ma H; Huang S; Yu D; Zhao L; Yang S; Liu J; Huang A; Cai C; Dai X; Zhang T
    Transl Oncol; 2017 Jun; 10(3):431-441. PubMed ID: 28448959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation-based indexes and clinicopathologic features are strong predictive values of preoperative circulating tumor cell detection in gastric cancer patients.
    Zheng L; Zou K; Yang C; Chen F; Guo T; Xiong B
    Clin Transl Oncol; 2017 Sep; 19(9):1125-1132. PubMed ID: 28315180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells in whole process management of gastrointestinal stromal tumor in a real-life setting.
    Zhang Q; Xu K; Chen M; Miao Y; Wang N; Xu Z; Xu H
    Saudi J Gastroenterol; 2020; 26(3):160-167. PubMed ID: 32386192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rare circulating tumor microemboli as a biomarker contributes to predicting early colorectal cancer recurrences after medical treatment.
    Hao YJ; Chang LW; Yang CY; Lo LC; Lin CP; Jian YW; Jiang JK; Tseng FG
    Transl Res; 2024 Jan; 263():1-14. PubMed ID: 37558203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
    Abdallah EA; Braun AC; Flores BCTCP; Senda L; Urvanegia AC; Calsavara V; Fonseca de Jesus VH; Almeida MFA; Begnami MD; Coimbra FJF; da Costa WL; Nunes DN; Dias-Neto E; Chinen LTD
    Oncologist; 2019 Sep; 24(9):e854-e863. PubMed ID: 30846515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
    Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
    J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients.
    Wu G; Yao Y; Bai C; Zeng J; Shi D; Gu X; Shi X; Song Y
    Thorac Cancer; 2015 May; 6(3):275-87. PubMed ID: 26273373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of circulating tumor cells and microemboli to predict diagnosis and prognosis in diffuse glioma.
    Qi Y; Xu Y; Yan T; Xiong W; Zhu X; Sun Q; Deng G; Yuan F; Ye L; Hu P; Liu B; Zhang S; Deng S; He Y; Wu G; Ye Q; Chen Q
    J Neurosurg; 2024 Sep; 141(3):673-683. PubMed ID: 38608304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of circulating tumor cells and analysis of clinicopathological factors in liver cancer.
    Cui K; Ou Y; Ning D; Li H; Xi Y; Li S
    J Cancer Res Ther; 2022 Apr; 18(2):452-460. PubMed ID: 35645114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage-dependent changes of preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in colorectal cancer.
    Jia J; Zheng X; Chen Y; Wang L; Lin L; Ye X; Chen Y; Chen D; Dettke M
    Tumour Biol; 2015 Dec; 36(12):9319-25. PubMed ID: 26104767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.
    Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W
    Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
    Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
    Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in giant cell tumor of the extremities.
    Chen Z; Zhao G; Chen F; Xia J; Jiang L
    BMC Cancer; 2019 Apr; 19(1):329. PubMed ID: 30961549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
    Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
    World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Combined Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Stage IV Advanced Gastric Cancer.
    Wang H; Ding Y; Li N; Wu L; Gao Y; Xiao C; Jiang H; Zheng Y; Mao C; Deng J; Wang H; Xu N
    Front Oncol; 2020; 10():841. PubMed ID: 32637353
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating tumor microemboli: Progress in molecular understanding and enrichment technologies.
    Umer M; Vaidyanathan R; Nguyen NT; Shiddiky MJA
    Biotechnol Adv; 2018; 36(4):1367-1389. PubMed ID: 29753882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.